Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000556645 | SCV000640815 | uncertain significance | Nemaline myopathy 2 | 2019-11-19 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with tryptophan at codon 1835 of the NEB protein (p.Arg1835Trp). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is present in population databases (rs199694315, ExAC 0.07%). This variant has not been reported in the literature in individuals with NEB-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mayo Clinic Genetic Testing Laboratories, |
RCV000556645 | SCV000782567 | uncertain significance | Nemaline myopathy 2 | 2017-01-11 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000556645 | SCV001462179 | uncertain significance | Nemaline myopathy 2 | 2020-01-17 | no assertion criteria provided | clinical testing |